CTOs on the Move

Avenu Medical

www.avenumedical.com

 
The Avenu Medical management team combines more than 100 years of experience in the medical device industry, with primary expertise in the less-invasive surgery markets and backgrounds in both corporate and venture funded start-up operations.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.avenumedical.com
  • 27123 Calle Arroyo Suite 2101
    San Juan Capistrano, CA USA 92675
  • Phone: 949.276.2483

Executives

Name Title Contact Details

Funding

Avenu Medical raised $12M on 10/31/2018

Similar Companies

Harbinger Medical

Harbinger Medical is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Westline Medical Management

Westline Medical Management is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medex Supply

With one of the largest catalogs of medical, surgical, and diagnostic supplies available online, Medex Supply can provide your facility with all the medical equipment necessary to ensure a healthy, safe, and sterile environment. Our extensive selection, low prices, fast shipping, and friendly, knowledgeable customer service makes Medex Supply a #1 favorite with universities, hospitals, doctors, nurses, schools, laboratories, government agencies, and more.

Intuitive Surgical

Intuitive Surgical, Inc. (NASDAQ: ISRG) is the global technology leader in minimally invasive robotic-assisted surgery. The Company`s da Vinci® Surgical System enables surgeons to operate minimally invasively through a few small incisions or the belly button from a nearby ergonomic console. The da Vinci System features a magnified 3D HD vision system and tiny wristed instruments that bend and rotate far greater than the human hand. As a result of this technology, da Vinci enables surgeons to operate with enhanced vision, precision and control.

ValenTx

ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.